7070 J . Org. Chem., Vol. 63, No. 20, 1998
Marshall and J iang
of hydroxy ester 18: [R]D +8.2 (c 0.45, CHCl3); 1H NMR (CDCl3,
300 MHz) δ 7.34 (m, 5 H), 4.58-4.92 (m, 10 H), 4.11 (q, J )
7.3 Hz, 2 H), 3.93 (m, 2 H), 3.51-3.77 (m, 4 H), 3.44 (m, 1 H),
3.38 (s, 3 H), 3.37 (s, 6 H), 2.27 (t, J ) 7.3 Hz, 2 H), 1.11-2.00
(m, 51 H), 0.87 (t, J ) 7.3 Hz, 3 H); 13C NMR (CDCl3, 75 MHz)
δ 173.8, 137.8, 128.3, 127.7, 127.6, 96.7, 94.1, 81.7, 79.8, 79.4,
79.2, 78.6, 73.3, 72.0, 69.7, 60.0, 55.7, 55.6, 55.5, 37.6, 34.3,
33.9, 31.8, 30.2, 29.7, 29.6, 29.5, 29.3, 29.2, 29.1, 29.0, 28.5,
27.9, 26.9, 26.5, 25.6, 24.9, 22.6, 14.2, 14.0. Anal. Calcd for
Bis-THF Ester 24. To a solution of 0.039 g (0.038 mmol)
of tosylate 23 in 1 mL of THF was added 0.15 mL (0.15 mmol)
of TBAF (1.0 M in THF). The reaction mixture was stirred at
50 °C for 12 h, quenched with brine, and extracted with ether.
The extracts were dried over MgSO4, filtered, and concentrated
under reduced pressure. The crude product was purified by
column chromatography on silica gel (elution with 15% EtOAc
in hexane) to afford 0.020 g (72%) of bis-THF ester: [R]D -6.0
(c 0.38, CHCl3); IR (film) 2925, 2855, 1728 cm-1 1H NMR
;
C
50H90O12: C, 67.99; H, 10.27. Found: C, 67.75; H, 10.10. The
(CDCl3, 300 MHz) δ 4.61-4.88 (m, 6 H), 4.12 (q, J ) 6.9 Hz,
2 H), 3.80-4.02 (m, 4 H), 3.65 (m, 1 H), 3.45 (m, 2 H), 3.38
(m, 9 H), 2.28 (t, J ) 7.7 Hz, 2 H), 1.00-2.05 (m, 51 H), 0.87
(t, J ) 6.9 Hz, 3 H); 13C NMR (CDCl3, 75 MHz) δ 173.8, 96.7,
96.6, 81.7, 80.8, 79.8, 79.2, 78.7, 60.1, 55.7, 55.6, 35.8, 34.3,
32.2, 31.9, 30.1, 30.0, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2,
29.1, 28.6, 28.5, 27.3, 27.1, 26.6, 25.5, 24.9, 22.6, 14.2, 14.1.
1
ee of this alcohol was judged to be >90% by H NMR analysis
of the (R)- and (S)-O-methyl mandelates (Supporting Informa-
tion).
Eth yl (12R,15R,16S,19R,20R,23R,24S)-15-[(Ben zyloxy-
m eth )oxy]-12-[(ter t-bu tyld im eth ylsilyl)oxy]-16,19,24-tr i-
(m eth oxym eth oxy)-20,23-oxid o-tetr a tr ia con ta n oa te (21).
To a mixture of 0.178 g (0.20 mmol) of alcohol 18 and 0.060 g
(0.88 mmol) of imidazole in 2 mL of DMF was added 0.076 g
(0.50 mmol) of TBSCl. The mixture was stirred at room
temperature for 12 h, quenched with water, and extracted with
ether. The extracts were washed with brine, dried over
MgSO4, filtered, and concentrated under reduced pressure. The
crude product was purified by column chromatography on
silica gel (elution with 10% EtOAc in hexane) to afford 0.190
g (95%) of TBS ether 21: [R]D +4.4 (c 0.5, CHCl3); IR (film)
Alcoh ol 26. To a solution of 0.02 mL (0.14 mmol) of
diisopropylamine in 0.5 mL of THF at 0 °C was added 0.04
mL (0.10 mmol) of BuLi. The mixture was stirred at 0 °C for
10 min and cooled to -78 °C. To it was added a solution of
0.016 g (0.02 mmol) of ester 24 in 0.5 mL of THF. The reaction
mixture was stirred at -78 °C for 60 min, and a solution of
0.006 g (0.03 mmol) of aldehyde 25 in 0.5 mL of THF was
added. After 30 min, the reaction was quenched with satu-
rated NH4Cl and extracted with ether. The extracts were
dried over MgSO4 and concentrated under reduced pressure.
To the residue was added 1 mL of THF followed by 0.1 mL
(0.10 mmol) of TBAF (1.0 M in THF). The reaction mixture
was stirred at room temperature for 30 min, quenched with
brine, and extracted with ether. The extracts were dried over
MgSO4, filtered, and concentrated under reduced pressure. The
crude product was purified by column chromatography (elution
with 40% EtOAc in hexane) to afford 0.013 g (78% for two
steps) of alcohol 26: 1H NMR (CDCl3, 300 MHz) δ 4.61-4.86
(m, 6 H), 4.18 (m, 1 H), 3.77-4.03 (m, 4 H), 3.65 (m, 1 H),
3.44 (m, 2 H), 3.38 (m, 9 H), 2.55 (m, 1 H), 1.03-2.10 (m, 51
H), 0.87 (t, J ) 6.9 Hz, 3 H).
2925, 2846, 1736, 1457 cm-1 1H NMR (CDCl3, 300 MHz) δ
;
7.34 (m, 5 H), 4.57-4.91 (m, 10 H), 4.12 (q, J ) 6.0 Hz, 2 H),
3.94 (m, 2 H), 3.64 (m, 4 H), 3.44 (m, 1 H), 3.38 (m, 9 H), 2.28
(t, J ) 7.7 Hz, 2 H), 1.13-1.98 (m, 51 H), 0.88 (m, 12 H), 0.03
(s, 6 H); 13C NMR (CDCl3, 75 MHz) δ 173.8, 137.9, 128.3, 127.7,
127.6, 96.7, 96.0, 94.0, 81.8, 81.4, 79.9, 79.5, 79.3, 78.6, 72.5,
69.6, 60.1, 55.8, 55.7, 55.6, 37.3, 34.4, 33.7, 31.9, 30.2, 30.0,
29.8, 29.4, 29.3, 29.2, 29.1, 28.6, 28.0, 26.7, 26.6, 25.9, 25.5,
25.2, 25.0, 24.8, 22.6, 18.1, 14.2, 14.1, -4.4.
Eth yl (12R,15S,16S,19R,20R,23R,24S)-12-[(ter t-Bu tyld i-
m e t h y ls ily l)o x y ]-15-h y d r o x y -16,19,24-t r i(m e t h o x y -
m eth oxy)-20,23-oxid otetr a tr ia con ta n oa te (22). A mixture
of 0.080 g (0.08 mmol) of ester 21 and 0.080 g of Pd-C (5%) in
1.5 mL of EtOAc-EtOH (3:1) was placed under an H2
atmosphere. The mixture was stirred for 12 h and filtered
through Celite. The solvent was removed under reduced
pressure and the residue was purified by column chromatog-
raphy on silica gel (elution with 20% EtOAc in hexane) to
afford 0.060 g (86%) of alcohol 22: [R]D +15.1 (c 0.37, CHCl3);
MOM-P r otected Squ a m osta tin -D 27. To a mixture of
0.012 g (0.016 mmol) of alcohol 26 and 0.025 mL (0.16 mmol)
of Et3N in 1.5 mL of CH2Cl2 at 0 °C was added 0.005 mL (0.035
mmol) of (CF3CO)2O. The reaction mixture was stirred at
room temperature for 16 h, quenched with saturated NaHCO3,
and extracted with ether. The extracts were dried over
MgSO4, filtered, and concentrated under reduced pressure. The
crude product was purified by column chromatography on
silica gel (elution with 60% Et2O in hexane) to afford 0.011 g
(94%) of MOM-protected squamostatin-D 27: IR 2925, 2837,
IR (film) 3466, 2925, 2846, 1728 cm-1; H NMR (CDCl3, 300
1
MHz) δ 4.59-4.86 (m, 6 H), 4.11 (q, J ) 6.0 Hz, 2 H), 3.95 (m,
2 H), 3.67 (m, 2 H), 3.47 (m, 3 H), 3.40 (s, 3 H), 3.38 (s, 6 H),
2.28 (t, J ) 7.7 Hz, 2 H), 1.11-2.00 (m, 51 H), 0.88 (m, 12 H),
0.04 (s, 6 H); 13C NMR (CDCl3, 75 MHz) δ 173.8, 144.4, 134.5,
129.6, 127.8, 96.8, 96.7, 96.2, 85.3, 81.8, 81.4, 79.7, 78.6, 78.5,
71.9, 60.1, 55.8, 55.6, 37.2, 34.4, 32.8, 31.9, 29.8, 29.7, 29.6,
29.4, 29.3, 29.2, 29.1, 28.6, 27.6, 27.1, 26.6, 25.8, 25.5, 25.1,
25.0, 22.6, 21.6, 18.0, 14.2, 14.1, 10.0, -4.5, -4.6.
1
1754 cm-1; H NMR (CDCl3, 300 MHz) δ 6.98 (s, 1 H), 4.99
(m, 1 H), 4.61-4.88 (m, 6 H), 3.79-4.05 (m, 4 H), 3.66 (m, 1
H), 3.45 (m, 2 H), 3.38 (m, 9 H), 2.26 (t, J ) 7.7 Hz, 2 H),
1.17-2.07 (m, 46 H), 1.40 (d, J ) 6.5 Hz, 3 H), 0.87 (t, J ) 7.3
Hz, 3 H).
Squ a m osta tin -D (28). A mixture of 0.010 g (0.013 mmol)
of the MOM-protected sqamostatin D 27 in 1.25 mL of 6 N
HCl-THF-CH3OH (1:2:2) was stirred for 12 h at room
temperature. The reaction mixture was quenched with water
and extracted with ether. The extracts were dried over
MgSO4, filtered, and concentrated under reduced pressure. The
crude product was purified by column chromatography on
silica gel (elution with 80% EtOAc in hexane) to afford 0.008
g (97%) of squamostatin-D 28: mp 112-113 °C (EtOAc-
hexane; lit.1 mp 112-113.5 °C); [R]D +8.4 (c 0.40, MeOH); lit.1
Tosyla te 23. To a solution of 0.053 g (0.06 mmol) of alcohol
22 in 0.5 mL of pyridine was added 0.070 g (0.35 mmol) of
p-TsCl. The mixture was stirred at room temperature for 12
h, quenched with water, and extracted with ether. The
extracts were washed with brine, dried over MgSO4, filtered,
and concentrated under reduced pressure. The crude product
was purified by column chromatography on silica gel (elution
with 20% EtOAc in hexane) to afford 0.059 g (95%) of tosylate
23: [R]D +10.9 (c 0.49, CHCl3); IR (film) 2916, 2846, 1728 cm-1
;
1H NMR (CDCl3, 300 MHz) δ 7.78 (d, J ) 8.9 Hz, 2 H), 7.31
(d, J ) 8.9 Hz, 2 H), 4.48-4.84 (m, 7 H), 4.12 (q, J ) 7.3 Hz,
2 H), 3.93 (m, 2 H), 3.61-3.76 (m, 2 H), 3.51 (m, 1 H), 3.41
(m, 1 H), 3.38 (s, 3 H), 3.36 (s, 3 H), 3.34 (s, 3 H), 2.43 (s, 3 H),
2.28 (t, J ) 8.1 Hz, 2 H), 1.04-2.01 (m, 51 H), 0.87 (t, J ) 6.2
Hz, 3 H), 0.94 (s, 9 H), -0.01 (s, 3 H), -0.03 (s, 3 H); 13C NMR
(CDCl3, 75 MHz) δ 173.8, 97.0, 96.7, 83.8, 81.8, 81.4, 80.8, 79.8,
78.6, 77.2, 76.8, 73.2, 72.4, 60.1, 55.8, 55.6, 47.7, 36.9, 34.3,
33.7, 31.9, 30.2, 30.1, 30.0, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3,
29.2, 29.1, 28.6, 27.6, 26.6, 25.9, 25.5, 25.3, 25.0, 22.6, 18.1,
15.2, 14.2, 13.9, 10.0, -4.45.
+7.9 (c 0.51, MeOH); IR (film) 3423, 2907, 2846, 1736 cm-1
;
1H NMR (CDCl3, 300 MHz) δ 6.98 (s, 1 H), 4.99 (m, 1 H), 3.84
(m, 5 H), 3.41 (m, 2 H), 2.26 (t, J ) 6.9 Hz, 2 H), 1.40 (d, J )
6.5 Hz, 3 H), 1.15-2.10 (m, 46 H), 0.88 (t, J ) 7.3 Hz, 3 H);
13C NMR (CDCl3 300 MHz) δ 173.9, 148.9, 134.3, 82.3, 82.2,
82.0, 79.3, 74.6, 74.4, 71.5, 35.6, 32.5, 32.4, 31.9, 29.7, 29.6,
29.5, 29.4, 29.3, 29.1, 28.6, 28.4, 27.4, 26.2, 26.0, 25.1, 22.7,
19.2, 14.1. Tr i-(R)-Mosh er ester : 1H NMR (CDCl3, 300 MHz)
δ 7.30-7.64 (m, 15 H), 6.97 (d, J ) 1.6 Hz, 1 H), 5.26 (m, 1 H),
4.99 (dd, J ) 1.5, 6.8 Hz, 1 H), 4.91 (m, 2 H), 3.97 (m, 1 H),
3.89 (q, J ) 6.9 Hz, 1 H), 3.75 (m, 1 H), 3.69 (q, J ) 7.4 Hz, 1